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elationships of maternal obesity, diabetes, and
nutrition during pregnancy with birth weight and
in turn relationships between birth weight and risk
of obesity and diabetes in later life have long been
observed (rev. in 1). Elucidating the etiology of these
relationships is challenging given that mammalian mothers
impart both genes and intrauterine environment to their
offspring. One factor that may play a role is epigenetics.
Epigenetic effects are deﬁned as heritable changes to DNA
structure that do not involve changes to the DNA sequence.
Unlike sequence changes, they can be reset or undone under
certain conditions such as in early development. Mecha-
nisms include changes in histone deacetylation and meth-
ylation of cytosines in CpG clusters (2).
An epigenetic phenomenon that is well-documented in
humans and may be the ﬁrst that springs to mind is ge-
nomic imprinting, whereby during germ cell development,
regulatory regions of certain genes are differentially meth-
ylated and expressed depending on whether the gene is
inherited from the mother or father (2). Imprinting impacts
several genes, including some in which mutation of the
expressed copy or disturbance of normal imprinting is
involved in both most cases of the rare transient neonatal
form of diabetes (3) and, based on recent evidence, ap-
parently some cases of polygenic type 1 (4) and 2 (5) dia-
betes as well.
However, other factors, including environmental stimuli,
can induce epigenetic changes as well (6–8); thus im-
printing is not the only epigenetic mechanism potentially
involved in diabetes and the related phenotypes of obesity
and metabolic syndrome (9). Moreover, imprinting is not
the only example of the phenomenon of parent-of-origin
effects, whereby the sex of the parent inﬂuences what
genes are expressed and in turn the risk for diabetes and
related conditions. Parent-of-origin effects can also in-
clude mitochondrial genome inheritance, which only occurs
through the maternal line, and maternal effects on the in-
trauterine environment (10).
There are well-characterized examples whereby mater-
nal genes appear to inﬂuence diabetes risk via both in-
heritance of maternal genetic variants and effects of the
maternal genetics in creating a hyperglycemic in utero
environment. For example, offspring of mothers carrying
an HNF1A mutation (maturity onset diabetes of the young
3) have an age of diabetes onset 8 years earlier than those
inheriting such a mutation from their fathers (11). On the
other hand, GCK (glucokinase) mutations increase risk for
both low birth weight and diabetes (maturity onset di-
abetes of the young 2) when inherited from either parent
but increase birth weight when carried by the mother due
to the hyperglycemic environment they create (12). In
contrast to HNF1A, GCK mutations have been found not
to have a maternal-speciﬁc effect on future glucose toler-
ance, apparently due to the lack of a role of GCK muta-
tions in b-cell dysfunction (13). The effects of intrauterine
environment on offspring adiposity and metabolism ap-
pear to be mediated by clear physiological mechanisms
and do not seem likely to require an epigenetic mecha-
nism.
Regardless, there is documented evidence in mammals
(rev. in 1) that maternal exposures such as nutrition status
can inﬂuence metabolic phenotypes through epigenetic
changes. Pregnant rats fed a diet moderately reduced in
protein content produce obese offspring with reduced
methylation of the promoter (upstream regulatory region)
of the gene PPARA, encoding peroxisome proliferator-
activated receptor (PPAR)-a, and concomitant increased
expression of PPAR-a and target genes involved in fatty
acid oxidation (14). The ability of neonatal leptin treat-
ment of these offspring rats to reverse hepatic hypo-
methylation of PPARA and overexpression and prevent
obesity (15) reinforces evidence for a direct causal pathway
of maternal malnutrition → epigenetic fetal modiﬁcation →
obese offspring. Evidence for a similar phenomenon in
humans has been purely epidemiological (e.g., the rela-
tionship between maternal nutrition during early preg-
nancy and adult adiposity observed in individuals born
during the Dutch famine [16]). That grandparental nutrition
status has been associated with diabetes and cardiovascular
disease risk (17) hints at the potential capability of nutri-
tional exposure to have epigenetic effects in humans, since
only DNA is transmitted in this case.
Up to this point in time there has been no reported di-
rect evidence in humans of a relationship between in utero
non–imprinting-related epigenetic changes and phenotype.
In the May issue of Diabetes, Godfrey et al. (18) report
the ﬁrst evidence that methylation status of gene pro-
moters in utero affects related phenotypes later in a child’s
development. They selected 28 genes identiﬁed in previous
animal studies (19,20) and 50 genes identiﬁed in a human
expression microarray study (for a total of 78 genes) of
15 umbilical cord samples as having the highest between-
subject variation in methylation. These 15 samples were
part of a larger study of 78 individuals in whom both um-
bilical cord DNA and adiposity measures (by dual energy
X-ray absorptiometry) at 9 years of age were available.
They then measured the percent methylation status of
these 78 gene promoters in the 78 subjects and evaluated
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COMMENTARYthe correlation with total fat mass, percent body fat, and
ratio of trunk to limb fat at age 9, and selected 5 genes for
further study based on initial analyses.
They found that for seven CpG promoter regions for
three genes (SOD1, RXRA, and eNOS), percent methyla-
tion was signiﬁcantly correlated with at least one of the
three traits (absolute value of r = 0.26–0.42, P = 0.043 to
,0.001). They then found that for one of the RXRA regions
for which methylation was positively correlated with adi-
posity, methylation status was also inversely correlated
with maternal carbohydrate intake, but not fat or protein
intake, during early pregnancy. Finally, they attempted
replication of the two strongest RXRA and eNOS signals in
an independent cohort of 239 6-year-old children with both
umbilical cord DNA and adiposity measurements. The
RXRA promoter methylation status was positively corre-
lated with adiposity in this second set with a similar effect
size and signiﬁcance to the original cohort.
In sum, methylation status of an RXRA promoter region
was strongly correlated directly with childhood adiposity
in two independent cohorts and inversely associated with
early pregnancy carbohydrate intake in the initial cohort.
Taken together, these ﬁndings suggest that effects of
the in utero environment on development inﬂuence later
metabolic parameters via epigenetic gene-speciﬁcp r o -
moter methylation, possibly mediated through maternal
diet. That RXRA in particular emerged as a gene whereby
methylation-modulated expression is related to adiposity
lends credence to the ﬁndings given the role of RXRA in
dimerizing with PPARs, and in turn lipid and carbohydrate
metabolism (21). Notably, neither RXRA nor any of the
genes identiﬁed in the study as having correlation of pro-
moter methylation with childhood adiposity are imprinted
genes (18).
What are the implications of this study? These data
provide much needed human evidence to complement the
growing body of animal data revealing that epigenetic
changes occurring during gestation, possibly maternal
nutrition-mediated, appear to inﬂuence adiposity and re-
lated metabolic phenotypes. Our direct knowledge of the
role of epigenetic effects on human variation and disease,
including obesity and potentially diabetes, is expanded
beyond imprinting, and our understanding of the role of
genes in obesity in general is expanded beyond the
effects of ﬁxed genetic variation. The results reveal some
of the value of studying human umbilical cord tissue to
understanding human variation and disease. In practical
clinical terms, the ﬁndings have the potential to rein-
force the importance of adequate nutrition counseling
during pregnancy (as noted by the authors [18]). If the
maternal dietary association is replicated and expanded,
it provides a mechanism whereby maternal diet might
have an impact long after birth on adiposity, which in turn
would be expected to inﬂuence risk for diabetes and its
complications.
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